SCR-LIP-000192 · Claim · machine-readable JSON →

This systematic review of molecular and cellular lipedema studies argues that the current staging system based on Wold (1951) is insufficient for the disease's clinical heterogeneity and proposes its revision to incorporate comorbidities (obesity, lymphedema), pre-surgical weight, and family history.

Claim at a glance

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Lipedema Research—Quo Vadis? — Ernst et al. (2023) ✓ verified — refining · review · 2023 · reading confidence: moderate
“Proposta de revisão do estadiamento atual para incluir: comorbidades (obesidade, linfedema), peso original pré-cirurgia, histórico familiar — estadiamento atual baseado em Wold 1951 é insuficiente para heterogeneidade clínica”
The article primarily reviews molecular/cellular research but explicitly addresses the staging classification, stating the current Wold 1951-based staging is insufficient and proposing revisions, which bears directly on the question about c [grade capped low->very_low per curated Oxford N6]

Populationwomen with lipedema

Conditionlipedema

Exposureproposed revised staging incorporating comorbidities and history

ComparatorWold (1951) staging system

Outcomeadequacy of staging for clinical heterogeneity

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.